|
1
|
Marulanda GA, Henderson ER, Johnson DA,
Letson GD and Cheong D: Orthopedic surgery options for the
treatment of primary osteosarcoma. Cancer Control. 15:13–20.
2008.PubMed/NCBI
|
|
2
|
Vander Griend RA: Osteosarcoma and its
variants. Orthop Clin North Am. 27:575–581. 1996.PubMed/NCBI
|
|
3
|
Kim SY and Helman LJ: Strategies to
explore new approaches in the investigation and treatment of
osteosarcoma. Cancer Treat Res. 152:517–528. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nardin A, Lefebvre ML, Labroquère K, Faure
O and Abastado JP: Liposomal muramyl tripeptide
phosphatidylethanolamine: Targeting and activating macrophages for
adjuvant treatment of osteosarcoma. Curr Cancer Drug Targets.
6:123–133. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie XK, Yang DS, Ye ZM and Tao HM:
Enhancement effect of adenovirus-mediated antisense c-myc and
caffeine on the cytotoxicity of cisplatin in osteosarcoma cell
lines. Chemotherapy. 55:433–440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oosterhoff D, Witlox MA, van Beusechem VW,
Haisma HJ, Schaap GR, Bras J, Kruyt FA, Molenaar B, Boven E,
Wuisman PI, et al: Gene-directed enzyme prodrug therapy for
osteosarcoma: Sensitization to CPT-11 in vitro and in vivo by
adenoviral delivery of a gene encoding secreted carboxylesterase-2.
Mol Cancer Ther. 2:765–771. 2003.PubMed/NCBI
|
|
7
|
Shavlakadze T, Winn N, Rosenthal N and
Grounds MD: Reconciling data from transgenic mice that overexpress
IGF-I specifically in skeletal muscle. Growth Horm IGF Res.
15:4–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang S, Alnaqeeb M, Simpson H and
Goldspink G: Cloning and characterization of an IGF-1 isoform
expressed in skeletal muscle subjected to stretch. J Muscle Res
Cell Motil. 17:487–495. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goldspink G: Mechanical signals, IGF-I
gene splicing, and muscle adaptation. Physiology (Bethesda).
20:232–238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carro E, Trejo JL, Núñez A and
Torres-Aleman I: Brain repair and neuroprotection by serum
insulin-like growth factor I. Mol Neurobiol. 27:153–162. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang LL, Xian CY and Wang YL: The MGF
expression of osteoblasts in response to mechanical overload. Arch
Oral Biol. 51:1080–1085. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mills P, Lafrenière JF, Benabdallah BF, El
Fahime M and Tremblay JP: A new pro-migratory activity on human
myogenic precursor cells for a synthetic peptide within the E
domain of the mechano growth factor. Exp Cell Res. 313:527–537.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Collins JM, Goldspink PH and Russell B:
Migration and proliferation of human mesenchymal stem cells is
stimulated by different regions of the mechano-growth factor
prohormone. J Mol Cell Cardiol. 49:1042–1045. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matheny RW Jr, Nindl BC and Adamo ML:
Minireview: Mechano-growth factor: A putative product of IGF-I gene
expression involved in tissue repair and regeneration.
Endocrinology. 151:865–875. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuo YH and Chen TT: Novel activities of
pro-IGF-I E peptides: Regulation of morphological differentiation
and anchorage-independent growth in human neuroblastoma cells. Exp
Cell Res. 280:75–89. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Armakolas A, Philippou A, Panteleakou Z,
Nezos A, Sourla A, Petraki C and Koutsilieris M: Preferential
expression of IGF-1Ec (MGF) transcript in cancerous tissues of
human prostate: Evidence for a novel and autonomous growth factor
activity of MGF E peptide in human prostate cancer cells. Prostate.
70:1233–1242. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Philippou A, Armakolas A, Panteleakou Z,
Pissimissis N, Nezos A, Theos A, Kaparelou M, Armakolas N,
Pneumaticos SG and Koutsilieris M: IGF1Ec expression in MG-63 human
osteoblast-like osteosarcoma cells. Anticancer Res. 31:4259–4265.
2011.PubMed/NCBI
|
|
18
|
Ates K, Yang SY, Orrell RW, Sinanan AC,
Simons P, Solomon A, Beech S, Goldspink G and Lewis MP: The IGF-I
splice variant MGF increases progenitor cells in ALS, dystrophic,
and normal muscle. FEBS Lett. 581:2727–2732. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Quesada A, Micevych P and Handforth A:
C-terminal mechano growth factor protects dopamine neurons: A novel
peptide that induces heme oxygenase-1. Exp Neurol. 220:255–266.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Li Z, Fu M, Bouras T and Pestell
RG: Signal transduction mediated by cyclin D1: From mitogens to
cell proliferation: A molecular target with therapeutic potential.
Cancer Treat Res. 119:217–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harry LE and Paleolog EM: From the cradle
to the clinic: VEGF in developmental, physiological, and
pathological angiogenesis. Birth Defects Res C Embryo Today.
69:363–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao S, Ma W, Zhang M, Tang D, Shi Q, Xu
S, Zhang X, Liu Y, Song Y, Liu L and Zhang Q: High expression of
CD147 and MMP-9 is correlated with poor prognosis of
triple-negative breast cancer (TNBC) patients. Med Oncol.
30:3352013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gou X, Chen H, Jin F, Wu W, Li Y, Long J,
Gong X, Luo M, Bi T, Li Z and He Q: Expressions of CD147, MMP-2 and
MMP-9 in laryngeal carcinoma and its correlation with poor
prognosis. Pathol Oncol Res. 20:475–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Daft PG, Yuan K, Warram JM, et al:
Alpha-CaMKII plays a critical role in determining the aggressive
behavior of human osteosarcoma. Mol Cancer Res. 11:349–359. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Crane JL and Cao X: Function of matrix
IGF-1 in coupling bone resorption and formation. J Mol Med.
92:107–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Durai R, Davies M, Yang W, Yang SY,
Seifalian A, Goldspink G and Winslet M: Biology of insulin-like
growth factor binding protein-4 and its role in cancer (review).
Int J Oncol. 28:1317–1325. 2006.PubMed/NCBI
|
|
28
|
van Golen CM, Schwab TS, Kim B, Soules ME,
Su Oh S, Fung K, van Golen KL and Feldman EL: Insulin-like growth
factor-I receptor expression regulates neuroblastoma metastasis to
bone. Cancer Res. 66:6570–6578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matheny RW Jr, Nindl BC and Adamo ML:
Minireview: Mechano-growth factor: A putative product of IGF-I gene
expression involved in tissue repair and regeneration.
Endocrinology. 151:865–875. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang ZY, Liu Y, Liu LX, Ding XY, Zhang H
and Fang LQ: RNAi-mediated MMP-9 silencing inhibits mouse melanoma
cell invasion and migration in vitro and in vivo. Cell Biol Int.
37:849–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Z, Ren Y, Wu QC, Lin SX, Liang YJ and
Liang HZ: Macrophage migration inhibitory factor enhances
neoplastic cell invasion by inducing the expression of matrix
metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma
cell lines. Chin Med J (Engl). 117:107–114. 2004.PubMed/NCBI
|
|
32
|
Yu W, Liu J, Xiong X, Ai Y and Wang H:
Expression of MMP9 and CD147 in invasive squamous cell carcinoma of
the uterine cervix and their implication. Pathol Res Pract.
205:709–715. 2009. View Article : Google Scholar : PubMed/NCBI
|
